NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/09/2024
Back to search
Official data from USPTO
CANINE CANCER GENOME PROJECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CANINE CANCER GENOME PROJECT
ST13
US500000097384135Class
42
Filing
97384135
Registration
7272225
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
01/09/2024
Trademark type
Word
Nice classes
42
Filing date
04/27/2022
Registration date
01/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/09/2024
Last transaction
01/09/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
05/22/2023
First use in commerce
05/22/2023
Drawing code
4
Owner type
99
Owner location
Port Washington, NY
Examiner
BUKER, RACHEL
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
A. F. (pessoa física)
Representatives
Jennifer R. Sandlin EVERSHEDS SUTHERLAND (US) LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical research services in the field of cancer; providing information about medical research and scientific informationinformation related to tumor genomes of canine cancers
Publications
History of USPTO decisions and trademark events.
24 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/09/2024
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
07/11/2023
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
07/10/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/10/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/10/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/10/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/10/2023
IUAA
USE AMENDMENT ACCEPTED
07/08/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/13/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/13/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/24/2023
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/23/2023
IUAF
USE AMENDMENT FILED
05/23/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/22/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/22/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
05/22/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/21/2023
GNRT
NON-FINAL ACTION E-MAILED
02/21/2023
CNRT
NON-FINAL ACTION WRITTEN
02/21/2023
DOCK
ASSIGNED TO EXAMINER
02/14/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/03/2022
NWAP
NEW APPLICATION ENTERED
04/30/2022
Continuous trademark protection
Get notified about every new filing that threatens CANINE CANCER GENOME PROJECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.